resveratrol has been researched along with Carcinoma, Pancreatic Ductal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, W; Li, J; Ma, J; Ma, Q; Qian, W; Qin, T; Wang, L; Xiao, Q; Xiao, Y; Yue, Y; Zhou, C | 1 |
| Aggarwal, BB; Anand, P; Diagaradjane, P; Gelovani, J; Guha, S; Harikumar, KB; Krishnan, S; Kunnumakkara, AB; Pandey, MK; Sethi, G | 1 |
2 other study(ies) available for resveratrol and Carcinoma, Pancreatic Ductal
| Article | Year |
|---|---|
Resveratrol slows the tumourigenesis of pancreatic cancer by inhibiting NFκB activation.
Topics: Animals; Carcinogenesis; Carcinoma, Pancreatic Ductal; Cells, Cultured; Ceruletide; Homeodomain Proteins; Metaplasia; Mice; Mice, Transgenic; NF-kappa B; Pancreatitis; Proto-Oncogene Proteins p21(ras); Resveratrol; Signal Transduction; Trans-Activators | 2020 |
Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Carcinoma, Pancreatic Ductal; Cell Cycle; Cell Proliferation; Cyclooxygenase 2; Deoxycytidine; Gemcitabine; Humans; Immunoenzyme Techniques; In Vitro Techniques; Male; Mice; Mice, Nude; NF-kappa B; Pancreatic Neoplasms; Resveratrol; Stilbenes; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2010 |